Northern Trust Corp Unicycive Therapeutics, Inc. Transaction History
Northern Trust Corp
- $658 Billion
- Q1 2025
A detailed history of Northern Trust Corp transactions in Unicycive Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 107,850 shares of UNCY stock, worth $64,710. This represents 0.0% of its overall portfolio holdings.
Number of Shares
107,850
Previous 58,181
85.37%
Holding current value
$64,710
Previous $45,000
35.56%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding UNCY
# of Institutions
31Shares Held
59.9MCall Options Held
0Put Options Held
0-
Vivo Capital, LLC Palo Alto, CA11.4MShares$6.82 Million1.76% of portfolio
-
Great Point Partners LLC Greenwich, CT11MShares$6.59 Million3.87% of portfolio
-
Octagon Capital Advisors LP New York, NY10MShares$6 Million1.9% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT9.39MShares$5.64 Million0.24% of portfolio
-
Logos Global Management LP San Francisco, CA5.08MShares$3.05 Million0.56% of portfolio
About Unicycive Therapeutics, Inc.
- Ticker UNCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,052,500
- Market Cap $9.03M
- Description
- Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Al...